Physician profile
Barton G Williams
NPI 1265540751
$14,425.65
in general payments reported to CMS, 2019-2025
80 companies · $2,334 in 2025
The $2,334 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,826 · 2020: $2,109 · 2021: $2,337 · 2022: $2,053 · 2023: $1,637 · 2024: $2,129 · 2025: $2,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,100.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,698.55 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $1,590.05 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $1,044.69 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Abbvie INC. | $926.21 | 2019-2025 | Ubrelvy, Qulipta |
| Glaxosmithkline, LLC. | $829.49 | 2019-2024 | Shingrix, Arexvy |
| Pfizer INC. | $769.99 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $524.74 | 2019-2025 | Jardiance |
| Abbott Laboratories | $483.62 | 2021-2025 | Epic, Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $444.76 | 2019-2023 | |
| Amarin Pharma, INC. | $393.03 | 2019-2022 | |
| Eisai INC. | $360.71 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $335.25 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $328.22 | 2019-2022 | |
| Bausch Health US, LLC | $303.96 | 2019-2025 | Wellbutrin, Aplenzin |
| Kowa Pharmaceuticals America, INC. | $300.13 | 2019-2022 |
Show all 78 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barton Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.